Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those ...
European countries are looking at buying millions of COVID-19 rapid tests mostly from Roche and Abbott , an EU document shows, as global production of the tests is stretched by a surge in infections.
Hosted on MSN
CPHO says it will stop offering free COVID-19 rapid tests once P.E.I.'s supply runs dry
Prince Edward Island's government says it will end free access to COVID-19 rapid antigen tests when its current supply runs out, citing low and stable rates of the virus over the past few months. In a ...
An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...
Positive tests have increased from 7.6% to 8.4% in a week. Whilst hospitalisations have also increased from 2.00 per 100,000 to 2.73 per 100,000. But it’s not just Covid, with UKHSA also reporting a ...
Anbio Biotechnology is a medical device firm develops in-vitro diagnostics, with stock volatility & thin public float. Read ...
FITBOOK magazine on MSN
These Three Pathogens Are Currently Making Germany Sick
A sharp increase in acute respiratory illnesses (ARE) is leading to overcrowded doctor’s offices and a growing number of sick ...
The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.
With the cold weather settling in, the chances of catching a cold, the flu, or even COVID increases. Rapid detection can save ...
Schuyler Wight is worried that Houston-based Occidental Petroleum could be contaminating the groundwater beneath his cattle ranch in Goldsmith, just northwest of Odessa. During a Texas Railroad ...
Healthcare is fast becoming a do-it-yourself project for patients. With a shortage of doctors, long wait times for appointments and an increasing prevalence of chronic diseases such as diabetes ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results